Remdesivir Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Recruiting | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT04593940 | Immune Modulators for Treating COVID-19 | |
| NCT04843761 | ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 | |
| NCT04501978 | ACTIV-3: Therapeutics for Inpatients With COVID-19 | |
| NCT04745351 | Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) | |
| NCT04694612 | Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal |